May.11 -- Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials. Chief Executive Officer Yin Weidong discusses CoronaVac's efficacy rate, exportation of the vaccine, and new findings on how it works against variants. He speaks exclusively with Bloomberg's Emma O'Brien.
